Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
Saved in:
| Title: | Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas. |
|---|---|
| Authors: | Mutter JA; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; University of Freiburg, Faculty of Biology, Freiburg, Germany., Alig SK; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Esfahani MS; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Lauer EM; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Mitschke J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Kurtz DM; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Kühn J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Bleul S; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Olsen M; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Liu CL; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Jin MC; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Macaulay CW; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Neidert N; Department of Neurosurgery, Medical Center-University of Freiburg, Freiburg, Germany.; Berta-Ottenstein-Programme for Clinician Scientists Medical Center, University of Freiburg, Freiburg, Germany., Volk T; Department of Neurology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Eisenblaetter M; Department of Radiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Rauer S; Department of Neurology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Heiland DH; Department of Neurosurgery, Medical Center-University of Freiburg, Freiburg, Germany., Finke J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Duyster J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Wehrle J; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Prinz M; Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.; Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany., Illerhaus G; Department of Hematology/Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany., Reinacher PC; Department of Stereotactic and Functional Neurosurgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Fraunhofer Institute for Laser Technology (ILT), Aachen, Germany., Schorb E; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Diehn M; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA., Alizadeh AA; Divisions of Oncology and Hematology, Department of Medicine, Stanford University, Stanford, CA., Scherer F; Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK) partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Mar 20; Vol. 41 (9), pp. 1684-1694. Date of Electronic Publication: 2022 Dec 21. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
